Curaleaf to list on the Toronto Stock Exchange (TSX) on Thursday

Curaleaf, one of the largest multi-state cannabis operators based in New York - including a cannabis company that sells in various US states - will be listed on the Toronto Stock Exchange (TSX) this Thursday, December 14, under the symbol CURA.

This strategic and financial move follows the conditional approval of the company's listing on the Toronto Stock Exchange in order, among other things, to access a larger number of investors on the Canadian exchange. The company's management, including CEO Matt Darin and the executive chairman Boris Jordan, will mark this milestone by ringing the TSX opening bell.

The decision to move to the Toronto Stock Exchange is part of a wider trend in the cannabis industry, with TerrAscend having done the same earlier in the year. Both companies are looking to improve their access to institutional investors on a global scale, and increase share liquidity over the long term.

In parallel with this listing, Curaleaf has carried out a major internal reorganization of its U.S. operations, as indicated in their press release. Curaleaf's internal reorganization is aimed at making the company more attractive to investors, complying with regulations, improving stock market transactions and adapting to the challenges and uncertainties of the cannabis industry.

In detail :

1. Access to a broader investor base: Listing on the Toronto Stock Exchange enables Curaleaf to attract a wider range of investors, including institutional investors. This broader investor base can improve the company's financial backing and liquidity.
2. Comply with regulatory requirements: The internal reorganization involves changes in the company's share and voting rights structure. These adjustments are likely to be made to comply with regulatory requirements, particularly in the context of evolving and complex U.S. cannabis regulations.
3. Increase share liquidity: By taking these strategic steps, Curaleaf intends to improve the long-term liquidity of its shares. This may make it easier for investors to buy and sell shares, and potentially increase the overall value of the company.
4. Solving regulatory uncertainties : The creation of a new class of non-voting exchangeable shares gives shareholders the option of converting their shares. This flexibility is designed to help investors cope with the uncertainties associated with cannabis regulations in the United States.
5. Improving corporate governance : Shareholder pacts and protection agreements focus on governance. These agreements define rights and obligations, providing a clear framework for decision-making and ownership, thus contributing to a stable, well-governed corporate structure.